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Abstract
Background: A low ankle-brachial index (ABI) is associated with increased risk of coronary heart
disease, stroke, and death. Regression model parameter estimates may be biased due to
measurement error when the ABI is included as a predictor in regression models, but may be
corrected if the reliability coefficient, R, is known. The R for the ABI computed from DINAMAP™
readings of the ankle and brachial SBP is not known.
Methods: A total of 119 participants in both the Atherosclerosis Risk in Communities (ARIC)
study and the NHLBI Family Heart Study (FHS) had repeat ABIs taken within 1 year, using a
common protocol, automated oscillometric blood pressure measurement devices, and technician
pool.
Results: The estimated reliability coefficient for the ankle systolic blood pressure (SBP) was 0.68
(95% CI: 0.57, 0.77) and for the brachial SBP was 0.74 (95% CI: 0.62, 0.83). The reliability for the
ABI based on single ankle and arm SBPs was 0.61 (95% CI: 0.50, 0.70) and the reliability of the ABI
computed as the ratio of the average of two ankle SBPs to two arm SBPs was estimated from
simulated data as 0.70.
Conclusion: These reliability estimates may be used to obtain unbiased parameter estimates if the
ABI is included in regression models. Our results suggest the need for repeated measures of the
ABI in clinical practice, preferably within visits and also over time, before diagnosing peripheral
artery disease and before making therapeutic decisions.
Background
The ratio of the ankle to the brachial systolic blood pres-
sure (SBP), the ankle-brachial index (ABI), is an indicator
of atherosclerotic vascular disease in the lower extremities
and a simple, non-invasive measure of subclinical athero-
sclerosis [1-9]. The ABI has been shown in cross-sectional
studies to be associated with cardiovascular disease (CVD)
risk factors including smoking [10-17] diabetes [10-
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sion [10,12,13] and low birth weight [14]. The ABI is asso-
ciated with other subclinical [10,22-25] and clinical
[10,12,13,23,25-28] CVD manifestations. Prospective
studies have found that those with ABI-defined lower
extremity arterial disease (LEAD) are approximately 1.5 to
2 times more likely to have a clinical CVD event [27,29-
31]. The ABI has a graded, inverse association with mor-
tality [32,33].
Regression parameters may be biased when predictors are
measured with error [34,35]. The parameter estimate for a
regression model with a single explanatory variable meas-
ured with error will be biased towards the null by a mul-
tiplicative factor R, the reliability coefficient. Parameter
estimates for additional covariates included in the model
may be biased in any direction. Unbiased parameter esti-
mates may be obtained using Stein estimators of true val-
ues [36] or other techniques if R is known [34,35].
To measure ankle SBP, Doppler ultrasound devices have
been used for many years to detect blood flow distal to an
occluding cuff. Many epidemiologic CVD studies have
included an ABI measured using either Doppler at the
ankle and sphygmomanometry at the arm, or Doppler at
both the ankle and the arm. In order to reduce interob-
server variation, several studies including the Atheroscle-
rosis Risk in Communities (ARIC) study [37] and the
NHLBI Family Heart Study (FHS) [38] have employed an
automated, oscillometric device to measure ankle and
brachial SBPs. Limited data regarding the repeatability of
ankle and arm SBPs measured with oscillometric devices
are available, but the repeatability of the ABI measured
with the widely-used DINAMAP™ has not been published
to our knowledge.
DINAMAP™ ankle and brachial SBPs were taken during
ultrasound exams using the same protocol, equipment,
and pool of sonographers in the ARIC study and the FHS.
Using repeat measures of the ABI taken within a year apart
for each of these studies, we estimate variance compo-
nents and reliability coefficients for ankle and brachial
SBPs and for the ABI. We also examined the effect of par-
ticipant characteristics on the ABI reliability.
Methods
Study population
The ARIC study cohort comprises 15,792 members aged
45–64 years of randomly selected households in four
United States communities: Forsyth County, North Caro-
lina; northwest suburbs of Minneapolis, Minnesota;
Washington County, Maryland; and African American res-
idents of Jackson, Mississippi [37,39]. ARIC participants
were examined at baseline between December 1986 and
January 1990 and were then examined every 3 years after
their baseline examination. Institutional review board
(IRB) approval for each examination cycle and for annual
follow-up were obtained by each participating field center
and the coordinating center. Informed consent itemized
the procedures consented to and any restrictions to the
use of biospecimen. The FHS population comprises 588
randomly-selected individuals (probands) and their fam-
ilies and 657 families with high coronary heart disease
(CHD) risk scores from three ongoing epidemiologic
studies in four communities: the Forsyth County, North
Carolina and Minneapolis, Minnesota cohorts of the
ARIC study; the Framingham Heart Study in Framingham,
Massachusetts; and the Health Family Tree Program in
Salt Lake City, Utah [38]. FHS participants were examined
in 1994–1995. IRB approval for the examination and a
follow-up were obtained by the participating field centers
and the coordinating center. Informed consent itemized
the procedures consented to and as well as restrictions to
the use of biospecimens.
Seven hundred ten ARIC study participants and their fam-
ilies participated in the FHS clinic examination: 267 ran-
domly-selected families, 340 families with high family
risk scores, and 103 black participants at Forsyth [38].
One member of each selected ARIC household was desig-
nated as proband; 585 total ARIC probands were exam-
ined in Phase II of the FHS, of whom 577 had an ARIC 6-
or 9-year follow-up visit when the ABI was to be meas-
ured.
Replicate ankle-brachial index measures taken for each of
the two studies were available for 335 ARIC probands,
120 of which were taken within 365 days. The ARIC ABI
measure closest to the FHS exam was chosen; 48 partici-
pants had 3 measures, but in all cases the second and third
measures were > 365 days apart. One participant who had
a difference between ABI measures that was more than 3
standard deviations (SDs) from the mean pair difference
was excluded. Of the remaining 119 participants, 25 (21
percent) had their first measure in the FHS and the second
at ARIC visit 3 and 22 (18 percent) had the second at ARIC
visit 4; 72 (61 percent) had the first ABI measure at ARIC
visit 3 and the second at the FHS exam. Measures were
taken an average of 228 days apart.
Ankle-brachial index measurement
Ankle and brachial blood pressures were obtained imme-
diately prior to the ultrasound examinations by the same
pool of 11 sonographers in both the FHS and ARIC fol-
low-up visit clinic exams, using the same protocol and
equipment [40,41]. With the participant resting in the
supine position, the cuff was placed using a contour wrap-
ping technique over the posterior tibial artery of one ankle
[42], selected based on the date. The cuff was then placed
over the brachial artery of the right arm, if anatomy per-Page 2 of 11
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1846 SX automated oscillometric device (Critikon, Inc.,
Tampa, FL). None of the 577 subjects in both studies had
a recorded blood pressure outside the device's detection
limits, <30 or >245 mmHg [43]; one subject was excluded
who had one ABI where the ankle systolic blood pressure
(SBP) was ≥ 75 mmHg more than the brachial SBP, a cri-
terion employed to exclude non-compressible arteries
[44]. The ABI was computed as the ratio of the ankle SBP
to the brachial SBP.
At the ARIC baseline survey, the ankle SBP was measured
with the participant prone before and after ultrasound
scanning of the popliteal artery, then brachial SBPs were
measured supine every 5 minutes during the carotid ultra-
sound. The ABI was computed as the ratio of the average
of the last two available ankle SBPs to the average of the
first two brachial SBPs.
Covariates
In the ARIC study and the FHS, hypertension was defined
as a sitting SBP > 140 mmHg, diastolic blood pressure >
Table 2: Variation in DINAMAP™ measurements of arm and ankle systolic blood pressure and the ankle-brachial index
Estimate Ankle SBP Arm SBP ABI
Mean (SD) of pair means, mmHg* 146.2 (23.76) 125.2 (19.57) 1.178 (0.1522)
Mean (SD) of pair differences, mmHg* -3.1 (20.67) 0.9 (15.24) -0.031 (0.1494)‡
Square root of variance components, mmHg*
Between-person† 21.4 (17.6,25.1) 18.0 (14.5, 1.3) 0.133 (0.112,0.150)
Within-person† 14.6 (12.7,16.5) 10.8 (8.9,12.4) 0.106 (0.091,0.121)
Total† 25.9 (22.8,28.7) 21.0 (18.3, 3.7) 0.170 (0.151,0.185)
Reliability coefficient† 0.682 (0.570, 0.772) 0.736 (0.622, 0.827) 0.612 (0.505, 0.699)
Within-person coefficient of variation, %† 10.0 (8.6, 11.2) 8.6 (7.1, 9.9) 9.0 (7.7, 10.2)
Pearson correlation coefficient 0.68 0.74 0.62
*Systolic blood pressures (SBPs) in mmHg; the ankle-brachial index (ABI) is without units.
Difference represents first minus second measure.
†Estimate (95% confidence interval).
‡ p < .05 for t-test of zero mean. Adjustment for the fixed effect of time changed very little the estimates of variance components.
Table 1: Characteristics of ABI reliability study subjects compared with the ARIC study cohort
ARIC baseline survey ARIC visit 3
Characteristic ARIC Minneapolis and 
Forsyth County
 (N = 8044)
ABI reliability study
 (N = 119)
ARIC Minneapolis and 
Forsyth County
 (N = 6839)†
ABI reliability study
 (N = 119)
Age, y* 54.2 (5.79) 55.0 (5.68) 60.2 (5.73) 61.0 (5.67)
Female, % 52.8 58.8 53.4 58.8
Race/ethnicity, %
White 93.3 84.0§ 94.5 84.0§
African American 6.3 16.0 5.1 16.0
American or Alaskan Indian 0.1 0 0.1 0
Asian or Pacific Islander 0.3 0 0.3 0
Field center, %
Forsyth County, NC 50.2 64.7‡ 48.9 64.7§
Minneapolis, Minn 49.8 35.3 51.1 35.3
Weight, kg* 76.0 (16.21) 75.7 (15.63) 78.1 (16.79) 78.4 (17.12)
Body mass index, kg/m2* 26.7 (4.73) 27.0 (4.78) 27.6 (5.03) 28.1 (5.34)
Diabetes, % 6.7 7.6 12.0 11.8
Smoking status, %
Current 26.8 23.5 18.2 19.3
Former 35.7 33.6 44.8 42.9
Never 37.5 42.9 37.0 37.8
Hypertension, % 26.6 26.9 34.4 35.3
Coronary heart disease, % 4.6 18.0§ 6.8 23.7§
Ankle brachial index* 1.14 (0.130) 1.13 (0.137) 1.19 (0.150) 1.17 (0.150)
*Numbers presented are mean (SD).
† ARIC participants with a visit 3 (6-year follow-up); for the ABI, N = 2295.
‡ 0.001 ≤ p < 0.01 for chi-square test comparing sample to source study population.
§ p < 0.001Page 3 of 11
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Table 3: Variation in DINAMAP™ measurements of the ankle-brachial index by subgroup defined at the first measurement
Square root of variance components
Subgroup N Between-person Within-person Total Reliability Coefficient Within-person CV, %
Overall 119 0.133 0.106 0.170 0.612 9.0
Age, y
≤ 62 66 0.124 0.104 0.162 0.587 8.9
> 62 53 0.144 0.107 0.180 0.643 9.1
Race/ethnicity
African American† 19 0.098 0.079 0.125 0.606 6.8
White 100 0.139 0.110 0.177 0.614 9.3
Gender
Male 49 0.140 0.102 0.173 0.653 8.4
Female 70 0.122 0.109 0.163 0.555 9.5
Field center
Forsyth County, NC 77 0.127 0.116* 0.172 0.545 9.9*
Minneapolis, Minn 42 0.142 0.086* 0.166 0.732 7.2*
Body mass index, kg/m2
≤ 27 61 0.141 0.083* 0.164 0.741* 7.1*
> 27 58 0.124 0.126* 0.178 0.495* 10.7*
Diabetes
No 106 0.134 0.099 0.167 0.646 8.4
Yes† 13 0.112 0.150 0.187 0.358 13.3
Hypertension
No 76 0.128 0.100 0.163 0.622 8.3
Yes 43 0.134 0.116 0.177 0.574 10.1
Hypertension rx switch‡
No 101 0.136 0.104 0.171 0.630 8.8
Yes† 18 0.114 0.115 0.162 0.498 9.9
Coronary heart disease
No 88 0.129 0.098 0.162 0.638 8.3
Yes 31 0.148 0.116 0.188 0.619 9.9
Legs
Same 51 0.115 0.118 0.165 0.486* 10.0
Different 68 0.146 0.094 0.174 0.706* 8.6
Days between measures
≤ 240 60 0.131 0.107 0.169 0.602 9.1
> 240 59 0.136 0.103 0.171 0.633 8.7
FHS sampling group
African American† 19 0.098 0.079 0.125 0.606 6.8
High family risk score 68 0.148 0.114 0.187* 0.629 9.7
Random sample 32 0.117 0.099 0.153* 0.581 8.2
*p < 0.05 for the difference between the two subgroups (the 95% bootstrapped confidence interval for the difference did not include zero).
†Proportion too small to perform statistical tests of differences.
‡"No" includes those who were either taking or not taking hypertension medication at the time of both ABI measures; "yes" includes those who 
were taking hypertension medication at the time of one ABI measure and not taking hypertension medication at the time of the other ABI measure.
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2 weeks prior to the examination. Diabetes was defined as
a fasting glucose level ≥ 7.8 mmol/L (140 mg/dL), a non-
fasting level ≥ 11.1 mmol/L (200 mg/dL), self-reported
history of diabetes, or the use of hypoglycemic agents. In
ARIC, prevalent CHD was defined as evidence of a prior
myocardial infarction on a 12-lead ECG, or self-reported
history of a physician-diagnosed heart attack, coronary
bypass surgery, or coronary angioplasty. In the FHS self-
reported, physician diagnosed coronary heart disease was
confirmed by review of hospital records.
Statistical analysis
For all statistical tests, two-sided p values < 0.05 were con-
sidered statistically significant. Characteristics of the ABI
reliability study subjects were compared to characteristics
of the ARIC source population at visits 1 and 3 using
Kruskal-Wallis two-sample tests for continuous variables
and Wilcoxon tests for categorical variables.
Each of the two observed values was assumed to represent
the sum of the true value and random within-person var-
iation [34]. Within-person variation may be due to meas-
urement error and physiologic variation. We assumed that
the within-person variation is independent of the value's
magnitude and that the within-person variation for each
of the two values are independent and identically distrib-
uted with mean zero and common variance. Estimates of
the between-person and within-person variances were
obtained with estimators derived using the method of
moments; similar estimates were obtained using SAS
PROC MIXED release 8.1 (SAS Institute, Inc., Cary, NC).
The reliability coefficient, R, was computed as the ratio of
the between-person variance to the total variance and can
be interpreted as the proportion of the total variance not
due to within-person variation, or as the correlation
between measures made at repeat visits for an individual.
The within-person coefficient of variation (CV) was com-
puted as 100 times the square root of the within-person
variance divided by the mean of the individual mean rep-
licates. These methods were applied to ankle and brachial
SBP measurements as well as to ABI. In addition, the mul-
tivariate generalization of this method was applied to pro-
duce the multivariate error covariance matrices and
between-person covariance matrices for ankle and arm
SBP and the component-wise ratios of the error and
between-person covariance to total covariance. (The diag-
onal elements of this matrix of ratios are the reliability
coefficients for ankle and arm SBP).
Because the arm SBPs and ABIs were not normally distrib-
uted, confidence intervals for the estimates of variance
components and reliability coefficients were derived from
300 bootstrap samples [45]. We compared variance com-
ponents, reliability coefficients, and CVs by levels of
important covariates, including the FHS sampling group.
Analyses did not account for the FHS sampling scheme.
To test subgroup differences, we constructed bootstrapped
95 percent confidence intervals for the differences; inter-
vals not including zero were deemed statistically signifi-
cant.
Bland-Altman plot showing the reproducibility of the ankle systolic blood res ureFigure 2
Bland-Altman plot showing the reproducibility of the 
ankle systolic blood pressure. The differences between 
the first and second measurements are plotted against the 
mean of the two measures with 95% limits of agreement 
(solid lines) and regression line (dashed line).
Bland-Altman plot showing the reproducibility of the ankle-br chial indexFigure 1
Bland-Altman plot showing the reproducibility of the 
ankle-brachial index. The differences between the first 
and second measurements are plotted against the mean of 
the two measures with 95% limits of agreement (solid lines) 
and regression line (dashed line).Page 5 of 11
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within-person variation from the ABI level, we compared
the estimated square root of the within-person variance
(i.e., the within-person SD) for those whose first of the
two repeat ABIs was at or below with those whose first ABI
was above the median ABI in the 119 reliability study sub-
jects. We also examined plots of the pair differences versus
the pair means for the ankle SBP, arm SBP, and ABI [46].
The ABI measured at the ARIC baseline survey is of inter-
est as a predictor of subsequent events. Because repeat
ankle and arm SBPs are available for the baseline survey,
the ABI is usually computed as the ratio of the average of
two ankle SBPs (in the same ankle) to the average of two
arm SBPs (in the right arm). We estimated the within-visit
multivariate error and total covariance matrices using
repeat ankle and arm SBP measures taken at the ARIC
baseline survey. The ratios of within-visit multivariate
error to total covariance matrices from the baseline survey
data were multiplied times the total variance in the ARIC/
FHS repeat data to partition the non-between person var-
iance found there into between-visit and within-visit com-
ponents. We simulated a two-measures-per-visit
repeatability dataset very much like the actual repeatabil-
ity dataset by taking each subject's mean of the two actual
repeated BP measures as the "true" BP values, and adding
independent random "between-visit" and "within-visit"
Gaussian measurement error, of size to make these two
variance components the same proportion of the total
variance as in the results of the repeatability study and the
baseline survey within-visit repeatability analysis. With
the simulated data, the reliability coefficient for the ABI
was computed as a ratio of means, along with the reliabil-
ity coefficient using just the first measure at each visit. This
was repeated 1000 times and the reliability coefficients
averaged.
Results
Of the 119 reliability study subjects, 70 (58.8 percent)
were women, 100 (84.0 percent) were white, and 77 (64.7
percent) were from the Forsyth County field center. At the
time of the first ABI measure, the mean age was 61.3 years,
mean weight 75.7 kg, mean body mass index 28.0 kg/m2,
and mean ABI 1.16; 13 (10.9 percent) had diabetes melli-
tus, 43 (36.1 percent) had hypertension, and 31 (26.0 per-
cent) had coronary heart disease. Characteristics of this
group were similar to those of the ARIC cohort in Minne-
apolis and Forsyth County at the time of the ARIC base-
line survey and at visit 3, except with respect to the
distribution of characteristics related to the FHS sampling
procedures: race/ethnicity, field center, and CHD preva-
lence (Table 1).
The estimated reliability coefficient for the ankle SBP was
0.682 (95 percent confidence interval (CI): 0.570, 0.772),
for the arm SBP was 0.736 (95 percent CI: 0.622, 0.827),
and for the ABI was 0.612 (95 percent CI: 0.505, 0.699)
(Table 2). These values are very close to estimated Pearson
correlation coefficients of 0.68, 0.74, and 0.62, respec-
tively, which have no underlying measurement error
model assumptions. Arm SBP measures appear to have
been more repeatable than ankle SBPs, as reflected by a
lower within-person SD (10.8 v. 14.6 mmHg), a lower
within-person CV (8.6 v. 10.0 percent), and a higher reli-
ability coefficient (0.736 v. 0.682). Exclusion of 4 data
pairs with either ABI measurement > 1.5 had little effect
on variance estimates.
The ankle SBP increased an average of 3.1 mmHg between
the first and second measures (p = 0.11), which resulted in
a statistically significant average increase of 0.031 in the
ABI (p = 0.02). Adjustment for the fixed effect of time (first
v. second measure) in an analysis of variance model
changed the variance component estimates very little. FHS
ankle SBP measures were an average of 3.2 mmHg higher
than ARIC measures (p = 0.10). ABI measures in the FHS
were 0.029 higher, on average, than ARIC measures (p =
0.03); controlling for the fixed effect of time reduced the
study difference to 0.024 (p = 0.09). No significant effects
of time or study were apparent for arm SBP.
The estimated ABI variance components differed in some
subgroups (Table 3). The within-person SD was statisti-
cally significantly smaller at the Minneapolis than at the
Forsyth County field center (0.086 versus 0.116). The
within-person SD was smaller in those with a BMI ≤ the
Bland-Altman plot showing the reproducibility of the brachial systolic blood res ureFigure 3
Bland-Altman plot showing the reproducibility of the 
brachial systolic blood pressure. The differences 
between the first and second measurements are plotted 
against the mean of the two measures with 95% limits of 
agreement (solid lines) and regression line (dashed line).Page 6 of 11
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(0.083 versus 0.126), resulting in a significantly greater
reliability coefficient in those with a lower compared to
those with a higher BMI (0.741 versus 0.495). Those
whose same ankles were measured had a statistically sig-
nificantly lower reliability coefficient (R = 0.486) than
those with different ankles measured (R = 0.706). There
were too few African American subjects, subjects with dia-
betes, and subjects who initiated or discontinued hyper-
tension treatment to test for subgroup differences. Within-
person SDs and reliability coefficients did not differ sig-
nificantly by age ≤ or > 62 years, gender, hypertension, or
by whether the time between measures was greater or less
than the median interval of 240 days. Except for the esti-
mated total variance, estimates did not differ significantly
between those in the high family risk score and the ran-
dom sample FHS sampling groups; the proportion of reli-
ability study subjects in the African American sampling
group was too small to test for differences.
Within-person SD estimates did not differ significantly
between those with an ABI ≤ 1.15 and those with an ABI
> 1.15 (0.113 versus 0.097), the median ABI in the 119
reliability study subjects. A plot of the pair differences ver-
sus the pair means revealed no obvious dependence of the
spread of the differences on the ABI level (Figures 1, 2, 3);
however, the difference between the first and second
measure decreased with increasing ABI level. The ankle
SBP differences did not depend statistically significantly
on ankle SBP level, but the arm pressure difference
decreased with increasing arm SBP. The two ankle pres-
sures differed by >10 mmHg in 73 (61.3 percent) subjects,
by >20 mmHg in 38 (31.9 percent) subjects, by >30
mmHg in 15 (12.6 percent) subjects, and by >40 mmHg
in 7 (5.9 percent) subjects. Arm pressures differed by >10
mmHg in 51 (42.9 percent) subjects, by >20 mmHg in 19
(16.0 percent) subjects, by >30 mmHg in 7 (5.9 percent)
subjects, and by >40 mmHg in 5 (4.2 percent) subjects.
The multivariate within-person error covariance and true-
to-total ratio covariance matrices for ankle and arm SBPs
estimated from the reliability study are given in Table 4.
The non-zero ankle-arm covariance suggests that the ankle
and arm SBP within-person errors were correlated (ρ =
0.56). The diagonal elements of the true-to-total compo-
nent-wise ratio covariance matrix represent the scalar reli-
ability coefficients.
The multivariate within-person (between-visit) error cov-
ariance and true-to-total component-wise ratio covariance
matrices estimated from the ARIC baseline survey are
given in Table 5. The within-visit ankle and arm errors
were essentially uncorrelated (ρ = 0). The correlation
between within-visit measures was high: 0.92 for ankle
SBP and 0.90 for arm SBP.
From ARIC baseline survey data, we also estimated the
within-visit variance and reliability of repeat ABIs, arbi-
trarily computed as the ratio of the first ankle to first arm
SBP and the ratio of the second ankle to second arm SBP.
The within-visit error variance for the ABI was 0.00636,
and the reliability coefficient was 0.681.
The ABI measured at the ARIC baseline survey, computed
as the ratio of the average of two ankle SBPs to the average
of two arm SBPs, is of interest as a predictor in regression
models. Using the estimates of the total and within-visit
errors (Tables 4 and 5, respectively), a dataset containing
two ankle and two arm SBPs at each of two visits was sim-
ulated by assuming that the pair means for the reliability
study represented the "true" values. For each of 1000 rep-
lications, the reliability coefficients were estimated for the
ABI computed at each visit as the ratio of the averages of
the within-visit values and the ABI computed as the ratio
of the first measures, and then the mean reliability coeffi-
cients over the replications taken. The result for the relia-
bility coefficient for single measures was 0.613, very near
that from the actual reliability study, and was 0.704 for
the reliability coefficient for the ratio of means.
Discussion
The within-person variance estimated from our data indi-
cates that the 95% confidence interval of a patient's ABI
would be the ABI value ± 0.21 if based on a single measure
of the ABI. Thus, our results suggest the need for repeated
measures of the ABI in clinical practice, if at all possible
Table 4: Multivariate  between-visit covariance matrices for ankle and arm systolic blood pressures estimated in reliability study 
subjects
Ankle SBP Arm SBP
Within-person covariance
Ankle SBP 213.6 88.3
Arm SBP 88.3 116.2
True/total ratio matrix
Ankle SBP 0.682 0.741
Arm SBP 0.741 0.736Page 7 of 11
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eral artery disease and before making therapeutic deci-
sions.
To our knowledge, few studies of the repeatability of ankle
or arm pressures measured with the DINAMAP™ have
been published, and the designs of the few published
studies do not include these same sources of variability.
No reliability coefficient has been published, of which we
are aware, for the ABI measured using the DINAMAP™ at
both the ankle and arm.
We have estimated within-person SDs of 14.6 mmHg for
ankle SBP and 10.8 mmHg for brachial SBP, with reliabil-
ity coefficients of 0.68 and 0.74, respectively, for
DINAMAP™ measures taken up to 1 year apart in a sample
of two middle-aged populations. Using a DINAMAP™
1846SX and a contour wrap at the ankle, Mundt et al [42]
found a within-person SD of 4.0 mmHg for ankle SBP and
2.5 mmHg for brachial SBP, with reliability coefficients of
0.94 and 0.92, respectively, for three repeat ankle and two
repeat arm measures one minute apart by one of two tech-
nicians among 71 adult volunteers aged 23–67 years; the
same ankle was used for all repeat measures. Ramanathan
et al [47] who also used a contour wrap at the ankle but
used a VitalCare DOX Model 506DXN automated oscillo-
metric device, estimated inter-reading intraclass correla-
tion coefficients (ICCs) of 0.83 for ankle SBP and 0.85 for
arm SBP for 3 repeat measures taken 30 minutes apart by
each of 2 investigators among 50 healthy volunteers with
a median age of 23 years. De Graaff et al [48] using a
DINAMAP™ Plus measured brachial SBPs twice by each of
two observers at each of 2 visits one week apart in 54 vas-
cular laboratory patients with a mean age of 66 years. Esti-
mates of within- and between-day, and within- and
between-week, ICCs are given, but no overall estimate is
presented with which we can compare our estimate of reli-
ability.
Using the contour wrapping technique, ankle SBP meas-
ured with the DINAMAP™ 1846SX were found to be about
3.0 mmHg lower, on average, than measures taken with
Doppler ultrasound [42]. Estimates of reliability were
comparable between the two methods, with a reliability
coefficient of 0.92 for Doppler and 0.94 for DINAMAP™
measures. This study did not include variation due to dif-
ferent days or legs, however. Fowkes et al [49] studied the
variability of Doppler ultrasound measures of ankle SBP,
brachial SBP, and the ABI in 24 peripheral artery disease
(PAD) patients and 11 volunteers without PAD aged 40–
74 years. Two measures were taken in each leg and the
right arm by each of two observers and then repeated two
weeks later. Reliability coefficients can be computed from
the results by summing all intraindividual variance com-
ponents. Regrettably, components of variance <10 were
not reported, but the range of possible values can be esti-
mated assuming unreported estimates were either all 10
or all 0. For Doppler ankle SBP, R was between 0.78 and
0.90 for normal subjects, and 0.37 and 0.46 for diseased
subjects. For Doppler arm SBP, R was between 0.87 and
0.91 for normal subjects, and was 0.68 for diseased sub-
jects. For the ABI, R was between 0.40 to 0.42 for diseased
subjects; the range of R computed from the reported
between-subject variance for normal subjects was implau-
sibly low. These values bracket those found in our reliabil-
ity study for DINAMAP™ SBP measures.
The estimated reliability coefficient for the ABI, 0.61, is
comparable to that for another measure of subclinical
atherosclerosis in the ARIC study, carotid intima-medial
thickness (IMT), but is lower than that found for other
measures. A reliability coefficient of 0.60 was estimated
for the mean carotid IMT, averaged over 3 arterial sites
bilaterally, in 279 subjects who participated in both the
ARIC study and the FHS and with carotid B-mode ultra-
sounds within a year apart (Diane Catellier, University of
North Carolina, unpublished manuscript, 2000). A relia-
bility coefficient of 0.67 was estimated for the mean
carotid IMT measured at three visits, 7–14 days apart in 36
volunteers from each of the four ARIC field centers [50];
measures of arterial distensibility and arterial compliance
had reliability coefficients of 0.67 and 0.77 [51]. Esti-
mated reliability coefficients for the ARIC study are 0.94
for both total and HDL-cholesterol [52], and 0.72 for
plasma fibrinogen [53].
The within-person variation in this reliability study
includes variation due to within and between observer,
Table 5: Multivariate within-visit covariance matrices for ankle and arm systolic blood pressures estimated in ARIC study participants
Ankle SBP Arm SBP
Within-person covariance
Ankle SBP 49.8 -0.0159
Arm SBP -0.0159 44.0
True/total ratio matrix
Ankle SBP 0.922 1.000
Arm SBP 1.000 0.900Page 8 of 11
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ability estimated from the reliability study data is lower
than the within-visit reliability estimated from ARIC base-
line survey data, because the reliability study's within-per-
son variability includes both between-visit and within-
visit variation. The between-visit variation includes varia-
tion due to different technicians, different machines, and
within-person biologic variation.
The reliability of the ABI was lower than that of either of
its components: the ankle SBP or arm SBP. The lower reli-
ability of the ankle SBP compared with that of the arm
SBP may be due to the greater difficulty in placing a cuff
on the more conical extremity.
Estimates of within-person variation in this reliability
study apply to measures using the methodology at ARIC
visits 3 and 4 and in the FHS, and may not apply to other
situations. Extreme care was taken in these studies to min-
imize measurement variation, including a detailed, com-
mon protocol and training and certification of
technicians. Reliability is likely to be lower in patient care
settings, where these methods are unlikely to be standard-
ized. Different oscillometric devices may vary in the algo-
rithms employed for determining systolic blood pressure
[54] and the accuracy of different oscillometric devices rel-
ative to sphygmomanometry has been found to differ
[55]; the repeatability of different devices may differ as
well. In addition, the reliability coefficient depends on the
total variance in the population and, therefore, the relia-
bility estimated in this study may not apply to other pop-
ulations. Assuming the same within-person variance, if
the total variance is lower than in the reliability study, as
it is in the ARIC baseline survey, then the reliability coef-
ficient would be lower than that estimated.
The reliability study defined the ABI as a ratio of single
blood pressure measurements. In the ARIC baseline sur-
vey, the ABI is defined using the mean of two ankle SBPs
(in the same leg) and the mean of two arm SBPs (in the
same arm), where the measures were taken approximately
5 minutes apart, and in the study of associations between
the ABI and potential disease outcomes this ABI will be
used. We have seen that the reliability coefficient for such
an ABI is notably higher than that computed directly from
the ARIC/FHS reliability study.
In clinical practice, repeated measures of the ABI should
be made, preferably within visits and over time before
diagnosing peripheral artery disease and before making
therapeutic decisions. Based on the within-person vari-
ance estimated here, the 95% confidence interval (1.96
times the within-person standard deviation) for one per-
son based on one measure of the ABI would be the ABI ±
0.21. In general, for the average of n measures, this inter-
val becomes the ABI average ± 0.21/√n, so the interval for
an ABI based on the average of two visits would be ABI ±
0.15, and average ABI ± 0.12 if based on 3 measures. The
reliability of oscillometric measurement of the brachial
SBP is not much greater than that of the ABI, and multiple
measures of the brachial SBP are recommended before
instituting hypertension treatment [56].
Most population-based epidemiologic studies have meas-
ured the ankle pressure in both legs, once [18] or twice
over the posterior tibial [10,12,57] or both over this artery
and the dorsalis pedis [58] on each ankle. The mean of the
repeated measurements on each ankle [10,12,57] or the
highest SBP for each ankle [58] was then used, and a sin-
gle ABI for the participant was computed using the mini-
mum of the ankle numerators of the two legs. ABI values
based on different protocols likely are associated with dif-
ferent levels of variability, the most robust (although not
necessarily the most sensitive to peripheral arterial dis-
ease), being those based on averaged repeated measures.
The effect of the choice of measurement protocol on the
ABI reliability would be important to know, but cannot be
assessed in this study since the ABI was defined in ARIC
using ankle pressure measured in one, randomly selected
leg.
The limited number of reliability study subjects in certain
subgroups limited our ability to test for subgroup differ-
ences. The significantly higher within-person SD at For-
syth might be because 7 technicians were employed at the
Forsyth County field Center and 4 at Minneapolis. The
Forsyth County field center had 25 percent African Amer-
ican subjects, while Minneapolis subjects were all white (p
< 0.001); Forsyth also had a higher proportion of subjects
with diabetes (14 percent v. 5 percent) than Minneapolis.
The center difference might also reflect different propor-
tions of subjects with higher within-person variation,
although the difference in reliability coefficients between
the two centers was not larger than chance alone would
explain and small numbers in these subgroups prevent
further analysis. Counter to intuition, the ABI had a lower
reliability in those whose ABI was measured in the same
leg than in those whose was measured in different legs;
this may represent a chance finding in this small study. It
would have been desirable to examine whether the relia-
bility differed in subjects with and without ABI-defined
LEAD (e.g., ABI < 0.9), but the limited sample size did not
allow for this analysis.
Individuals are often categorized as having LEAD or not
by categorizing the observed ABI as below or above a cut-
point, typically 0.9. This categorical variable is then
included as a predictor in regression models. An upper
limit of normal for the ABI also has been proposed [57] to
assess arterial stiffness and medial arterial calcification.Page 9 of 11
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non-differential measurement error may result in differ-
ential misclassification when the probability of disease is
related to the level of the continuous variable [59]. Result-
ing regression parameter estimates are biased, but meth-
ods that assume non-differential misclassification may
not correctly adjust these estimates.
Conclusion
The reliability of the ABI computed as the ratio of single
ankle and arm oscillometric SBPs was found to be 0.61.
The reliability of the ABI computed as the ratio of the aver-
age of two ankle SBPs to two arm SBPs was estimated from
simulated data as 0.70. These reliability estimates may be
used to obtain unbiased parameter estimates if the ABI is
included in regression models. If ankle and arm SBP are
included as separate predictors in a regression model, cor-
rected parameter estimates may be obtained by taking the
multivariate reliability into account.
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